Join Index
For Startups
For Investors
For Brands
For Analysts
Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Pricing
Data Tools
Innovation Services
About Index
Index
By TNW
Log in
Register
Syndesi Therapeutics
216
Syndesi Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
Syndesi Therapeutics is developing molecules that uniquely modulate the synaptic vesicle protein SV2A, which plays a central role in synaptic transmission (the communication between neurons in the brain).
Suggest edits
Type
B2c
Founded
2018
Raised
$21M
Follow us
Companies in the same industry
Amgen Inc.
Prosensa
eTheRNA Immunotherapies
Acticor Biotech
Patara Pharma, LLC
DMD Therapeutics
Disarm Therapeutics
NextStep Robotics
Aelin Therapeutics
Cedilla Therapeutics
Alexa global traffic share
